CFD
IMVT icon

Creative Financial Designs’s Immunovant IMVT Stock Holding History

Creative Financial Designs’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,965
Closed -$77K – 1283
2022
Q1 		$77K Buy
13,965
+1,515
+12% +$9.44K 0.01% 474
2021
Q4 		$106K Sell
12,450
-1,492
-11% -$12.3K 0.02% 432
2021
Q3 		$121K Sell
13,942
-25
-0.2% -$226 0.02% 407
2021
Q2 		$148K Buy
13,967
+4,875
+54% +$68.1K 0.03% 363
2021
Q1 		$146K Buy
9,092
+5,105
+128% +$135K 0.03% 338
2020
Q4 		$184K Buy
3,987
+707
+22% +$32.7K 0.04% 268
2020
Q3 		$115K Buy
+3,280
New +$98.7K 0.03% 316

Other funds holding IMVT

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Creative Financial Designs's IMVT Position: Q2 2022 in Review

Creative Financial Designs sold out of Immunovant (IMVT) in Q2 2022, closing a stake of 13,965 shares — an estimated $77K sold.

Creative Financial Designs first reported a position in IMVT in Q3 2020 and held it in 7 quarters. The position peaked at $184K in Q4 2020. 94 funds tracked by Wall St. Rank hold IMVT as of Q2 2022.

  • Creative Financial Designs reported no remaining Immunovant position as of Q2 2022 after selling out during the quarter.
  • Creative Financial Designs sold 13,965 Immunovant shares in Q2 2022, an estimated $77K.
  • Creative Financial Designs first reported a position in Immunovant in Q3 2020 and held it in 7 quarters.
  • Creative Financial Designs's Immunovant position peaked at $184K in Q4 2020.
  • 94 funds tracked by Wall St. Rank held Immunovant as of Q2 2022.

Based on Creative Financial Designs's 13F filing for Q2 2022, filed 1 Aug 2022.